机构：[1]Department of Anesthesiology, University of Virginia, Charlottesville, Virginia 22901, USA; Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China.诊疗科室麻醉科首都医科大学附属天坛医院[2]Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China.诊疗科室麻醉科首都医科大学附属天坛医院[3]Department of Anesthesiology, University of Virginia, Charlottesville, Virginia 22901, USA.
出处：
ISSN：
摘要：
Dexmedetomidine is often used in anesthesia and critical care medicine practice to sedate patients. Its neuroprotective effects have been shown in various ischemic and hemorrhagic brain injury models of animals. Randomized clinical trials have indicated that dexmedetomidine can improve outcome of patients under intensive care. Clinical trials are needed to determine whether dexmedetomidine can provide neuroprotection against ischemic and hemorrhagic stroke.
语种：
外文
PubmedID：
第一作者：
第一作者机构：[1]Department of Anesthesiology, University of Virginia, Charlottesville, Virginia 22901, USA; Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100050, China.
推荐引用方式(GB/T 7714)：
Wang Yunzhen,Han Ruquan,Zuo Zhiyi.Dexmedetomidine-induced neuroprotection: is it translational?[J].Translational perioperative and pain medicine.2016,1(4):15-19.
APA：
Wang Yunzhen,Han Ruquan&Zuo Zhiyi.(2016).Dexmedetomidine-induced neuroprotection: is it translational?.Translational perioperative and pain medicine,1,(4)
MLA：
Wang Yunzhen,et al."Dexmedetomidine-induced neuroprotection: is it translational?".Translational perioperative and pain medicine 1..4(2016):15-19
